CPR Therapeutics Inc. received a $512,000 National Science Foundation Project Grant award under the NSF Technology, Innovation, and Partnerships program to develop an automated multimodal cardiopulmonary resuscitation system. The one-year award will support preclinical research and optimization studies using a swine model of cardiac arrest to design a next-generation proof-of-concept prototype. The system aims to improve outcomes for sudden cardiac arrest patients by integrating multiple...
Compact Medical Inc. received a $255,925 Small Business Innovation Research Phase I Project Grant from the National Science Foundation to develop a novel respiratory bag-valve-mask resuscitator. The grant was awarded on August 15, 2021 under the NSF's Engineering program (CFDA #47.041) and will support product development activities through February 28, 2022. The Engineering program seeks to foster innovation in engineering research and education to improve quality of life and economic strength....
The National Science Foundation (NSF) awarded Compact Medical Inc., a for-profit medical device manufacturer, a $999,931 Cooperative Agreement under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The funding supports the development and testing of a novel, adjustable bag-valve-mask (BVM) resuscitator device that allows emergency providers to deliver customized air volumes and pressures based on patient body size. This advanced resuscitator aims to address issues with...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant awarded $274,440 to Vine Medical Inc., a for-profit manufacturing company, to develop a proof-of-concept for a self-deploying endotracheal intubation device. The proposed soft robotics system aims to achieve over a 90% first-pass intubation success rate, which would improve patient outcomes and reduce complications during emergency airway management procedures. The device is designed to...
Sperry Medtech Inc. received a $255,382 Project Grant award from the National Science Foundation Division of Industrial Innovation on March 1, 2021 to develop a novel respiratory ventilator for clinical care in response to COVID-19. The award was made under the NSF's Engineering program (CFDA 47.041), which seeks to improve quality of life and economic strength through engineering research and innovation. With this funding, Sperry Medtech will work to advance a new ventilator design that...
This Project Grant award from the National Science Foundation (CFDA 47.084 - NSF Technology, Innovation, and Partnerships program) provides $274,274 to X-Cor Therapeutics Inc., a minority-owned small disadvantaged business in Washington, DC, to develop a novel respiratory dialysis system for treating chronic obstructive pulmonary disease (COPD) patients. The project aims to optimize a prototype that can efficiently remove excess carbon dioxide from the blood of COPD patients, with the goal of...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $295,924 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Convergent Engineering, Inc. to develop a prototype decision support system for personalizing mechanical ventilation care. The proposed system aims to simplify the use of esophageal pressure measurements and provide decision support to optimize ventilator settings and prevent complications for ventilated patients. Key objectives include...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,160,157 Project Grant (CFDA 93.837 Cardiovascular Diseases Research) to Liberandum Technologies, Inc. in San Francisco, CA. The goal of this Phase I Small Business Innovation Research (SBIR) project is to develop and test a bidirectional synchronous flow-controlled ventilation system to improve oxygenation and ventilation in patients with acute respiratory distress syndrome (ARDS). The ventilation system aims to provide gentle...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $793,956 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Resuscitation Innovations LLC, doing business as Advancedcpr Solutions LLC, located in Edina, Minnesota. The funding supports the development of innovative treatments to improve survival rates for patients experiencing refractory cardiac arrest, a condition where current interventions are ineffective. The project aims to advance "HEAD...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837), focuses on developing and demonstrating a high-volume manufacturing technology for microfluidic oxygenators. The goal is to enable safer, simpler treatment of respiratory failure through extracorporeal membrane oxygenation (ECMO) therapy. The $294,063 award to Biomembretics, Inc. will fund a two-phase project to: 1) define the target...